Cargando…

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales:	Iorio, Giuseppe Carlo, Ricardi, Umberto, Dal Pra, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708345/ https://www.ncbi.nlm.nih.gov/pubmed/33312960 http://dx.doi.org/10.3389/fonc.2020.617302

Ejemplares similares

The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care()
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients
por: Huang, Qingfang, et al.
Publicado: (2023)

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2020)

A “SHort course Accelerated RadiatiON therapy” (SHARON) During and Beyond the COVID-19 Pandemic
por: Morganti, Alessio G., et al.
Publicado: (2022)

Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches
por: Pham, Thao-Nguyen, et al.
Publicado: (2023)

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2017)

European radiation oncology after one year of COVID-19 pandemic
por: Slotman, Ben J., et al.
Publicado: (2021)

Lymphopenia in Esophageal Cancer: What Have We Learned?
por: Wang, Jia-Lin, et al.
Publicado: (2021)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
por: van Rossum, Peter S. N., et al.
Publicado: (2023)

Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
por: Ellsworth, Susannah G.
Publicado: (2018)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
por: Mantovani, Cristina, et al.
Publicado: (2021)

Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
por: Guo, Zijing, et al.
Publicado: (2021)

Effect of COVID-19 pandemic on practice in European radiation oncology centers()
por: Slotman, Berend J., et al.
Publicado: (2020)

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2016)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
por: Cottini, Francesca, et al.
Publicado: (2021)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
por: d’Engremont, Christelle, et al.
Publicado: (2021)

Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A post hoc analysis of a randomized controlled trial
por: Ni, Wenjie, et al.
Publicado: (2022)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020)

Sinonasal Side Effects of Chemotherapy and/or Radiation Therapy for Head and Neck Cancer: A Literature Review
por: Riva, Giuseppe, et al.
Publicado: (2022)

Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside
por: Montoya, Chris, et al.
Publicado: (2023)

A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer
por: Xu, Zhiyuan, et al.
Publicado: (2022)

Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer
por: Kang, Byung-Hee, et al.
Publicado: (2022)

PB2572: LYMPHOPENIA RATE; A FREE EPIDEMIOLOGICAL BIOMARKER FOR COVID-19 PANDEMIC
por: Helali, Intissar, et al.
Publicado: (2023)

Disease Control With Delayed Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Shelan, Mohamed, et al.
Publicado: (2019)

Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients
por: Levis, Mario, et al.
Publicado: (2023)

Fever, splenomegaly and lymphopenia in sarcoidosis
por: Ravaglia, Claudia, et al.
Publicado: (2013)

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
por: Yahalom, Joachim, et al.
Publicado: (2020)

COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020)

Is lymphopenia different between SARS and COVID‐19 patients?
por: Yan, Shaomin, et al.
Publicado: (2021)

Over Expressed TKTL1, CIP-2A, and B-MYB Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients
por: Chiarini, Anna, et al.
Publicado: (2019)

Lymphopenia in SARS
por: Panesar, Nirmal S
Publicado: (2003)

A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
por: Wang, Xin, et al.
Publicado: (2020)

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
por: Liu, FangJie, et al.
Publicado: (2022)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
por: Ebrahimi, Saba, et al.
Publicado: (2021)

Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy
por: Chen, Fang, et al.
Publicado: (2021)

Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model
por: Telarovic, Irma, et al.
Publicado: (2022)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
por: Jing, Wang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ru0fsgb060sjr9ao7hbav49eep